clobetasol and Myelodysplastic-Syndromes

clobetasol has been researched along with Myelodysplastic-Syndromes* in 2 studies

Other Studies

2 other study(ies) available for clobetasol and Myelodysplastic-Syndromes

Article	Year
Chronic graft-versus-host disease of the male genitalia: an underrecognized manifestation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017, Volume: 15, Issue:7 Topics: Administration, Topical; Adult; Chronic Disease; Clobetasol; Diagnosis, Differential; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lichenoid Eruptions; Male; Myelodysplastic Syndromes; Penile Diseases; Stomatitis	2017
Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report. Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 115, Issue:4 The authors present a case demonstrating the success of topical tacrolimus (TAC) therapy with custom trays in the treatment of oral chronic graft-versus-host disease (cGVHD). The 41-year-old male patient initially responded to topical steroid therapy (clobetasol propionate 0.05% ointment) applied both topically and with flexible carrier trays, but later became refractory to this potent topical agent. Topical TAC therapy with flexible carrier trays and systemic prednisone therapy was initiated.. The patient responded favorably with the change to topical TAC therapy with custom trays (and oral prednisone). His oral cGVHD lesions resolved within a period of 4 weeks. The improvement has remained stable at 14 months of follow-up.. This is the first case reported with regard to the successful resolution of steroid recalcitrant cGVHD successfully treated with topical TAC with custom trays. Topics: Administration, Topical; Adult; Clobetasol; Drug Carriers; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mouth Diseases; Myelodysplastic Syndromes; Recurrence; Tacrolimus	2013

Article

Year

Chronic graft-versus-host disease of the male genitalia: an underrecognized manifestation.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017, Volume: 15, Issue:7

Topics: Administration, Topical; Adult; Chronic Disease; Clobetasol; Diagnosis, Differential; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lichenoid Eruptions; Male; Myelodysplastic Syndromes; Penile Diseases; Stomatitis

2017

Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report.

Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 115, Issue:4

The authors present a case demonstrating the success of topical tacrolimus (TAC) therapy with custom trays in the treatment of oral chronic graft-versus-host disease (cGVHD). The 41-year-old male patient initially responded to topical steroid therapy (clobetasol propionate 0.05% ointment) applied both topically and with flexible carrier trays, but later became refractory to this potent topical agent. Topical TAC therapy with flexible carrier trays and systemic prednisone therapy was initiated.. The patient responded favorably with the change to topical TAC therapy with custom trays (and oral prednisone). His oral cGVHD lesions resolved within a period of 4 weeks. The improvement has remained stable at 14 months of follow-up.. This is the first case reported with regard to the successful resolution of steroid recalcitrant cGVHD successfully treated with topical TAC with custom trays.

Topics: Administration, Topical; Adult; Clobetasol; Drug Carriers; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mouth Diseases; Myelodysplastic Syndromes; Recurrence; Tacrolimus

2013